Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Lellouche

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Presse Medicale (Paris, France : 1983)|September 23, 1995
[Ocular venous thromboses: relationship with the G1691A mutation on the gene of factor V]I Dorval, F Lellouche, E Ribaute
Prostaglandins|September 1, 1990
Enzyme immunoassay measurement of the urinary metabolites of thromboxane A2 and prostacyclinF Lellouche, A Fradin, G Fitzgerald, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1991
Selective inhibition of platelet-derived thromboxane A2 in patients with lupus anticoagulant using low doses aspirin as assessed by enzyme immunoassayF Lellouche, C Falcon, L Carreras, et al.
Presse Medicale (Paris, France : 1983)|May 20, 1995
[Presence of G1691A mutation on the gene of factor V in arterial thrombosis]F Lellouche, I Dorval, J Dewilde, et al.
Human Genetics|April 17, 1998
Allele frequencies of hereditary hemochromatosis gene mutations in a local population of west BrittanyP Jézéquel, M Bargain, F Lellouche, et al.
Presse Medicale (Paris, France : 1983)|November 5, 1997
[Uncommon venous or arterial thromboses: don't forget to look for hyperhomocysteinemia]F Lellouche, P Jezequel, I Dorval, et al.
Agents and Actions. Supplements|January 1, 1992
Increased production of platelet-derived thromboxane in patients with lupus anticoagulantJ Maclouf, F Lellouche, M Martinuzzo, et al.
Revue Neurologique|July 18, 2001
[Bartonella henselae meningoencephalitis]P Tattevin, F Lellouche, F Bruneel, et al.
Blood|December 1, 1991
Imbalance of thromboxane/prostacyclin biosynthesis in patients with lupus anticoagulantF Lellouche, M Martinuzzo, P Said, et al.
Blood|April 3, 1999
C282Y hemochromatosis mutation does not contribute to hypercoagulability in a factor V Leiden population referred to venous thrombosisF Lellouche, I Dorval, J M Corvisier, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Presse Medicale (Paris, France : 1983)|September 23, 1995
[Ocular venous thromboses: relationship with the G1691A mutation on the gene of factor V]I Dorval, F Lellouche, E Ribaute
Prostaglandins|September 1, 1990
Enzyme immunoassay measurement of the urinary metabolites of thromboxane A2 and prostacyclinF Lellouche, A Fradin, G Fitzgerald, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1991
Selective inhibition of platelet-derived thromboxane A2 in patients with lupus anticoagulant using low doses aspirin as assessed by enzyme immunoassayF Lellouche, C Falcon, L Carreras, et al.
Presse Medicale (Paris, France : 1983)|May 20, 1995
[Presence of G1691A mutation on the gene of factor V in arterial thrombosis]F Lellouche, I Dorval, J Dewilde, et al.
Human Genetics|April 17, 1998
Allele frequencies of hereditary hemochromatosis gene mutations in a local population of west BrittanyP Jézéquel, M Bargain, F Lellouche, et al.
Presse Medicale (Paris, France : 1983)|November 5, 1997
[Uncommon venous or arterial thromboses: don't forget to look for hyperhomocysteinemia]F Lellouche, P Jezequel, I Dorval, et al.
Agents and Actions. Supplements|January 1, 1992
Increased production of platelet-derived thromboxane in patients with lupus anticoagulantJ Maclouf, F Lellouche, M Martinuzzo, et al.
Revue Neurologique|July 18, 2001
[Bartonella henselae meningoencephalitis]P Tattevin, F Lellouche, F Bruneel, et al.
Blood|December 1, 1991
Imbalance of thromboxane/prostacyclin biosynthesis in patients with lupus anticoagulantF Lellouche, M Martinuzzo, P Said, et al.
Blood|April 3, 1999
C282Y hemochromatosis mutation does not contribute to hypercoagulability in a factor V Leiden population referred to venous thrombosisF Lellouche, I Dorval, J M Corvisier, et al.
Pageof 3